Breast Cancer

Showing NaN - NaN of 213

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Spain (Alpelisib, Metformin, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Alicante, Spain
  • +17 more
Aug 23, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)

Enrolling by invitation
  • Ovarian Cancer
  • Breast Cancer
  • Boca Raton, Florida
  • +98 more
Aug 22, 2022

Breast Cancer Trial in Worldwide (Amcenestrant, Palbociclib, Alpelisib)

Active, not recruiting
  • Breast Cancer
  • Denver, Colorado
  • +30 more
Aug 18, 2022

Breast Cancer Trial in Worldwide (LY3484356)

Recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Aug 17, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Chandler, Arizona
  • +226 more
Aug 11, 2022

Breast Cancer Trial in Worldwide (Abraxane, Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Adelaide, South Australia, Australia
  • +66 more
Aug 10, 2022

Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)

Completed
  • Breast Cancer
  • Cancer
  • Nivolumab
  • +2 more
  • Whittier, California
  • +35 more
Jul 14, 2022

Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Breast Cancer
  • Fayetteville, Arkansas
  • +22 more
Aug 8, 2022

First Line Therapy for Locally Advanced and/or Metastatic Breast

Completed
  • Breast Cancer
  • Córdoba, Andalucía, Spain
  • +35 more
Aug 4, 2022

Breast Cancer, Uterine Cancer, Ovarian Cancer Trial in Denmark, France, Spain (GEN1047 is a bispecific antibody that induces

Recruiting
  • Breast Cancer
  • +3 more
  • GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive cells.
  • Copenhagen, Denmark
  • +5 more
Jul 25, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Chandler, Arizona
  • +166 more
Jul 21, 2022

Breast Cancer Trial in Worldwide (biological, drug, other, procedure)

Active, not recruiting
  • Breast Cancer
  • nivolumab
  • +6 more
  • Mobile, Alabama
  • +255 more
Jul 21, 2022

Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +167 more
Jul 19, 2022

Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan)

Recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • San Diego, California
  • +90 more
Jul 19, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +495 more
Jun 15, 2022

Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is

Completed
  • Cervix Cancer
  • +3 more
  • Madrid, Spain
    Julia Albano Polo
Jul 4, 2022

Breast Cancer Trial in Worldwide (Amcenestrant (SAR439859), Letrozole)

Terminated
  • Breast Cancer
  • Tucson, Arizona
  • +31 more
Jun 27, 2022

Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +132 more
Apr 26, 2022

Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Amcenestrant-matching placebo
  • +5 more
  • Daphne, Alabama
  • +299 more
May 5, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Cancer, Chemo, Sentinel Lymph Node Trial in Spain (Axillary Radiotherapy, Lymphadenectomy)

Recruiting
  • Breast Cancer
  • +4 more
  • Axillary Radiotherapy
  • Lymphadenectomy
  • Badalona, Barcelona, Spain
  • +23 more
Apr 19, 2022